Skip to Main content
  • Cost
  • Patient Information
  • Healthcare Professional Site
  • Important Safety Information
  • $0 Savings Offer
  • Talk To A Doctor
Ubrelvy-logo
  • WHY UBRELVY
    • Why Ubrelvy
    • EARLY MIGRAINE SIGNS
  • TREATING MIGRAINE
    • Treating Migraine
    • FAQS
  • REAL PATIENT STORIES
  • RESOURCES
  • SAVINGS
  •  
  • Cost
  • Patient Information
  • Healthcare Professional Site
  • Important Safety Information

UBRELVY SITE MAP

  • Home
  • Why UBRELVY
  • Savings
  • Resources
  • Treating Migraine
  • Real Patient Stories
  • Email Signup
  • UBRELVY COMPLETE SAVINGS CARD SIGNUP
  • Telemedicine
  • Healthcare Professional Site
  • Patient Information
  • Important Safety Information
  • Privacy Policy
  • Contact Us

IMPORTANT SAFETY INFORMATION

Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, or itraconazole, or if you are allergic to UBRELVY or any of its ingredients.

Before taking UBRELVY, tell your healthcare provider about all your medical conditions, including if you:

  • Have high blood pressure
  • Have circulation problems in your fingers and toes
  • Have liver problems
  • Have kidney problems
  • Are pregnant or plan to become pregnant
  • Are breastfeeding or plan to breastfeed

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Your healthcare provider can tell you if it is safe to take UBRELVY with other medicines.

UBRELVY may cause serious side effects, including:

  • Allergic reactions: Most reactions happened within hours after taking UBRELVY and were not serious. Some reactions may occur days after taking UBRELVY. Call your healthcare provider or get emergency help right away if you have swelling of the face, mouth, tongue, or throat or trouble breathing.
  • High blood pressure: New or worsening of high blood pressure can happen. Contact your healthcare provider if you have an increase in blood pressure.
  • Raynaud’s phenomenon: A type of circulation problem can worsen or happen. Raynaud’s phenomenon can lead to your fingers or toes feeling numb, cool, or painful, or changing color from pale, to blue, to red. Contact your healthcare provider if these symptoms occur.

The most common side effects of UBRELVY are nausea (4%) and sleepiness (3%). These are not all of the possible side effects of UBRELVY.

What is UBRELVY® (ubrogepant)?

UBRELVY is a prescription medicine used for the acute treatment of migraine attacks with or without aura in adults. UBRELVY is not used to prevent migraine headaches.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more.

US-UBR-250100

Please see full Patient Information.

ubrelvy-footer-logo

Why Ubrelvy

Treating Migraine

Real Patient Stories

Resources

Savings

UBRELVY Complete

For questions, call
1.844.4.UBRELVY (1.844.482.7358),
Monday–Friday, 8:00 am to 8:00 pm Eastern Time.

  • instagram
  • facebook
  • tiktok
  • youtube
  • twitter

Why Ubrelvy

Treating Migraine

Real Patient Stories

UBRELVY Complete

For questions, call
1.844.4.UBRELVY (1.844.482.7358),
Monday–Friday, 8:00 am to 8:00 pm Eastern Time.

Resources

Savings

  • Savings Card
  • Telemedicine
  • Healthcare Professional Site
  • Site Map
  • Accessibility Statement
  • Contact Us
  • Terms of Use
  • Privacy Notice
  • Consumer Health Data Privacy Notice
  • Cookies Settings
  • Your Privacy Choices
 

This site is intended for U.S. consumers only.

© 2024 AbbVie. All rights reserved.
All trademarks are the property of their respective owners.

US-UBR-230475

SPEAK TO A DOCTOR ONLINE AND FIND OUT IF UBRELVY IS RIGHT FOR YOU

Use telemedicine to connect to a doctor. Here's how:

  • chat bubbles icon

    Answer a few simple questions about your migraine attacks and current treatment plan.

  • stethoscope inside phone icon

    Connect directly to a licensed healthcare provider or schedule an appointment at your convenience. A fee is charged by UpScript.

  • rx paper icon

    If a prescription is written, you can pick it up at a local pharmacy you choose.

AS A REMINDER, YOU MAY BE ELIGIBLE TO PAY AS LITTLE AS $0* A MONTH FOR YOUR UBRELVY PRESCRIPTION. TEXT UBRELVY TO 48764† TO GET STARTED.


*Eligibility: Available to patients with commercial insurance coverage for UBRELVY who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly and annual maximums, may apply. This is not health insurance. For full Terms, Conditions, and Eligibility Criteria, visit UBRELVY.com/savings-terms. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy.
†Msg & data rates may apply. You are not required to consent as a condition of receiving goods or services. You can reply HELP for help. You can reply STOP to opt out at any time. By texting UBRELVY to 48764, you agree to AbbVie's Mobile T&C at https://abbv.ie/USMobileTerms and Privacy Notice at https://abbv.ie/corpprivacy. Full Prescribing Information available at https://www.rxabbvie.com/pdf/ubrelvy_pi.pdf.
UpScript‡, one of many telemedicine platforms, lets you speak with a healthcare provider to see if UBRELVY is right for you, all from the comfort of your own home.
‡Third-party website; does not constitute an endorsement or recommendation by AbbVie.

By clicking “Talk Now” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the qualifications of any physician associated with the third-party website, or the quality of medical care any of those physicians can provide. AbbVie makes no guarantees that using the third-party website will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential physician. ABBVIE AND ITS RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE THIRD-PARTY WEBSITE.

If you agree to the above, click “talk now” to proceed to the third-party website. If you do not agree to the above, click “BACK TO SITE” to remain on UBRELVY.com.

TALK NOW
BACK TO SITE

THANK YOU FOR SIGNING UP

Due to popular demand, UBRELVY is temporarily unavailable but should be back in pharmacies shortly

SPEAK TO A DOCTOR ONLINE AND FIND OUT IF UBRELVY IS RIGHT FOR YOU

Use telemedicine to connect to a doctor. Here's how:

  • chat bubbles icon

    Answer a few simple questions about your migraine attacks and current treatment plan.

  • stethoscope inside phone icon

    Connect directly to a licensed healthcare provider or schedule an appointment at your convenience. A fee is charged by UpScript.

  • rx paper icon

    If a prescription is written, you can pick it up at a local pharmacy you choose.

AS A REMINDER, YOU MAY BE ELIGIBLE TO PAY AS LITTLE AS $0* A MONTH FOR YOUR UBRELVY PRESCRIPTION. TEXT UBRELVY TO 48764† TO GET STARTED.


*Eligibility: Available to patients with commercial insurance coverage for UBRELVY who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly and annual maximums, may apply. This is not health insurance. For full Terms, Conditions, and Eligibility Criteria, visit UBRELVY.com/savings-terms. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy.
†Msg & data rates may apply. You are not required to consent as a condition of receiving goods or services. You can reply HELP for help. You can reply STOP to opt out at any time. By texting UBRELVY to 48764, you agree to AbbVie's Mobile T&C at https://abbv.ie/USMobileTerms and Privacy Notice at https://abbv.ie/corpprivacy. Full Prescribing Information available at https://www.rxabbvie.com/pdf/ubrelvy_pi.pdf.
UpScript‡, one of many telemedicine platforms, lets you speak with a healthcare provider to see if UBRELVY is right for you, all from the comfort of your own home.
‡Third-party website; does not constitute an endorsement or recommendation by AbbVie.

By clicking “Talk Now” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the qualifications of any physician associated with the third-party website, or the quality of medical care any of those physicians can provide. AbbVie makes no guarantees that using the third-party website will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential physician. ABBVIE AND ITS RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE THIRD-PARTY WEBSITE.

If you agree to the above, click “talk now” to proceed to the third-party website. If you do not agree to the above, click “BACK TO SITE” to remain on UBRELVY.com.

TALK NOW
BACK TO SITE

YOU ARE LEAVING THE SITE TO CONNECT WITH A PROFESSIONAL

By clicking “Continue” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the American Migraine Foundation (“AMF”), a division of the American Headache Society®, any healthcare provider (“HCP”), or the qualifications of any HCP associated with AMF, or the quality of medical care any of those HCPs can provide. Further, you also acknowledge and agree that AbbVie makes no guarantees that using AMF will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential HCP. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential HCP. ABBVIE AND ITS AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE AMF WEBSITE. Please be aware of that AMF may have its own set of terms and conditions and privacy policy for which AbbVie has no responsibility.

If you agree to the above, click “Continue” to proceed to the AMF website. If you do not agree to the above, click “Cancel” to remain on the current website.

Continue
Cancel

YOU ARE LEAVING THE SITE TO CONNECT WITH A PROFESSIONAL

By clicking “Continue” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the American Migraine Foundation (“AMF”), a division of the American Headache Society®, any healthcare provider (“HCP”), or the qualifications of any HCP associated with AMF, or the quality of medical care any of those HCPs can provide. Further, you also acknowledge and agree that AbbVie makes no guarantees that using AMF will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential HCP. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential HCP. ABBVIE AND ITS AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE AMF WEBSITE. Please be aware of that AMF may have its own set of terms and conditions and privacy policy for which AbbVie has no responsibility.

If you agree to the above, click “Continue” to proceed to the AMF website. If you do not agree to the above, click “Cancel” to remain on the current website.

Continue
Cancel

                    

US-UBR-230448

PROGRAM TERMS, CONDITIONS, AND ELIGIBILITY CRITERIA:

  1. This offer is valid for patients 18 years of age or older and is good for use only with a valid prescription for UBRELVY® (ubrogepant) tablets at the time the prescription is filled by the pharmacist and dispensed to the patient.
  2. This offer is not valid for use by patients enrolled in Medicare, Medicaid, or other federal or state programs (including any state pharmaceutical assistance programs) or private indemnity or HMO insurance plans that reimburse you for the entire cost of your prescription drugs. If at any time a participating patient begins receiving prescription drug coverage under any federal, state, or government-funded healthcare program, the patient will no longer be eligible for this program and must cease participation. This offer is not valid for cash-paying patients.
  3. Eligible commercially insured patients may pay as little as $0 per monthly prescription fill. Patient out-of-pocket expense will vary; check with your pharmacist for your co-pay discount. Restrictions, including monthly, quarterly, and/or annual maximums, may apply.
  4. Subject to all other terms and conditions, a commercially insured patient whose plan covers UBRELVY may receive up to a maximum annual savings of $7,000 per calendar year, solely for the patient’s benefit, under this program. Commercially insured patients for whom coverage is not available because the insurer has not established a coverage review process may be eligible to receive up to 4 one-month fills at no charge. Under this program, once an insurer has established a review process for coverage requests, commercially insured patients may receive up to a maximum of 2-month fills at no charge for an FDA-approved indication while coverage is pending.
  5. Patients may not seek reimbursement for value received from this savings program from any third-party payers.
  6. AbbVie reserves the right to rescind, revoke, or amend this offer without notice.
  7. Offer good only in the USA, including Puerto Rico, at participating retail pharmacies. Patients residing in or receiving treatment in certain states may not be eligible to participate in this program.
  8. Void if prohibited by law, taxed, or restricted.
  9. This card is not transferable. The selling, purchasing, trading, or counterfeiting of this card is prohibited by law.
  10. This card has no cash value and may not be used in combination with any other discount, coupon, rebate, free trial, or similar offer for the specified prescription.
  11. This offer is not health insurance.
  12. By redeeming this offer, you acknowledge that you are an eligible commercially insured patient and that you understand and agree to comply with the above terms and conditions.

For questions about the program, including savings on mail-order prescriptions, or to activate your card ID, please call 1-844-577-6239.

To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy

IMPORTANT SAFETY INFORMATION

Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, or itraconazole, or if you are allergic to UBRELVY or any of its ingredients.

IMPORTANT SAFETY INFORMATION

Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, or itraconazole, or if you are allergic to UBRELVY or any of its ingredients.

IMPORTANT SAFETY INFORMATION

Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, or itraconazole, or if you are allergic to UBRELVY or any of its ingredients.

IMPORTANT SAFETY INFORMATION

Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, or itraconazole, or if you are allergic to UBRELVY or any of its ingredients.

IMPORTANT SAFETY INFORMATION

Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, or itraconazole, or if you are allergic to UBRELVY or any of its ingredients.

Before taking UBRELVY, tell your healthcare provider about all your medical conditions, including if you:

  • Have high blood pressure
  • Have circulation problems in your fingers and toes
  • Have liver problems
  • Have kidney problems
  • Are pregnant or plan to become pregnant
  • Are breastfeeding or plan to breastfeed

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Your healthcare provider can tell you if it is safe to take UBRELVY with other medicines.

UBRELVY may cause serious side effects, including:

  • Allergic reactions: Most reactions happened within hours after taking UBRELVY and were not serious. Some reactions may occur days after taking UBRELVY. Call your healthcare provider or get emergency help right away if you have swelling of the face, mouth, tongue, or throat or trouble breathing.
  • High blood pressure: New or worsening of high blood pressure can happen. Contact your healthcare provider if you have an increase in blood pressure.
  • Raynaud’s phenomenon: A type of circulation problem can worsen or happen. Raynaud’s phenomenon can lead to your fingers or toes feeling numb, cool, or painful, or changing color from pale, to blue, to red. Contact your healthcare provider if these symptoms occur.

The most common side effects of UBRELVY are nausea (4%) and sleepiness (3%). These are not all of the possible side effects of UBRELVY.

What is UBRELVY® (ubrogepant)?

UBRELVY is a prescription medicine used for the acute treatment of migraine attacks with or without aura in adults. UBRELVY is not used to prevent migraine headaches.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more.

US-UBR-250100